BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19744931)

  • 1. Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR.
    Palijan A; Fernandes I; Bastien Y; Tang L; Verway M; Kourelis M; Tavera-Mendoza LE; Li Z; Bourdeau V; Mader S; Yang XJ; White JH
    J Biol Chem; 2009 Oct; 284(44):30264-74. PubMed ID: 19744931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression.
    Palijan A; Fernandes I; Verway M; Kourelis M; Bastien Y; Tavera-Mendoza LE; Sacheli A; Bourdeau V; Mader S; White JH
    J Biol Chem; 2009 Oct; 284(44):30275-87. PubMed ID: 19744932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms.
    Fernandes I; Bastien Y; Wai T; Nygard K; Lin R; Cormier O; Lee HS; Eng F; Bertos NR; Pelletier N; Mader S; Han VK; Yang XJ; White JH
    Mol Cell; 2003 Jan; 11(1):139-50. PubMed ID: 12535528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.
    Calderon MR; Verway M; An BS; DiFeo A; Bismar TA; Ann DK; Martignetti JA; Shalom-Barak T; White JH
    J Biol Chem; 2012 Mar; 287(12):8662-74. PubMed ID: 22277651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo.
    Liu XF; Bagchi MK
    J Biol Chem; 2004 Apr; 279(15):15050-8. PubMed ID: 14722073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
    Band AM; Laiho M
    Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex.
    Suzuki A; Sanda N; Miyawaki Y; Fujimori Y; Yamada T; Takagi A; Murate T; Saito H; Kojima T
    J Biol Chem; 2010 Apr; 285(18):13444-53. PubMed ID: 20200160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human THAP7 is a chromatin-associated, histone tail-binding protein that represses transcription via recruitment of HDAC3 and nuclear hormone receptor corepressor.
    Macfarlan T; Kutney S; Altman B; Montross R; Yu J; Chakravarti D
    J Biol Chem; 2005 Feb; 280(8):7346-58. PubMed ID: 15561719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
    Sharma D; Saxena NK; Davidson NE; Vertino PM
    Cancer Res; 2006 Jun; 66(12):6370-8. PubMed ID: 16778215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corepressor recruitment by agonist-bound nuclear receptors.
    White JH; Fernandes I; Mader S; Yang XJ
    Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.
    Singh RR; Barnes CJ; Talukder AH; Fuqua SA; Kumar R
    Cancer Res; 2005 Nov; 65(22):10594-601. PubMed ID: 16288053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
    Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
    Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional repression of estrogen receptor α signaling by SENP2 in breast cancer cells.
    Nait Achour T; Sentis S; Teyssier C; Philippat A; Lucas A; Corbo L; Cavaillès V; Jalaguier S
    Mol Endocrinol; 2014 Feb; 28(2):183-96. PubMed ID: 24422630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha.
    Leong H; Sloan JR; Nash PD; Greene GL
    Mol Endocrinol; 2005 Dec; 19(12):2930-42. PubMed ID: 16051668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer.
    Riolo MT; Cooper ZA; Holloway MP; Cheng Y; Bianchi C; Yakirevich E; Ma L; Chin YE; Altura RA
    J Biol Chem; 2012 Mar; 287(14):10885-93. PubMed ID: 22334690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 6 regulates estrogen receptor alpha in uterine leiomyoma.
    Wei LH; Torng PL; Hsiao SM; Jeng YM; Chen MW; Chen CA
    Reprod Sci; 2011 Aug; 18(8):755-62. PubMed ID: 21421902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex regulation of LCoR signaling in breast cancer cells.
    Jalaguier S; Teyssier C; Nait Achour T; Lucas A; Bonnet S; Rodriguez C; Elarouci N; Lapierre M; Cavaillès V
    Oncogene; 2017 Aug; 36(33):4790-4801. PubMed ID: 28414308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
    Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K
    Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
    Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
    Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.